| Description |
melatonin receptor 1A |
c-Maf inducing protein |
| Image |
|
No pdb structure |
| GO Annotations |
Cellular Component |
|
|
| Molecular Function |
|
|
| Biological Process |
|
|
| Pathways |
|
|
| Drugs |
|
|
| Diseases |
|
|
| GWAS |
- Depressive symptoms measurement (somatic complaints domain) ( 26997408)
- Job-related exhaustion in shift workers ( 28364478)
- Obesity ( 21552555)
|
- Adiponectin levels ( 22479202 24105470)
- Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin) ( 23648065)
- Age-related cataracts ( 25352737)
- Cadmium levels ( 26025379)
- Dehydroepiandrosterone sulphate levels ( 28887542)
- Diastolic blood pressure ( 28135244 27841878)
- HDL cholesterol ( 24097068 30275531 25961943 20686565)
- HDL cholesterol levels ( 28334899 30698716)
- HDL cholesterol levels in current drinkers ( 30698716)
- HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) ( 30698716)
- HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) ( 30698716)
- HDL cholesterol levels x short total sleep time interaction (2df test) ( 31719535)
- Heel bone mineral density ( 30598549 28869591)
- Height ( 31562340)
- Hematology traits ( 30576415)
- High density lipoprotein cholesterol levels ( 29403010)
- Medication use (agents acting on the renin-angiotensin system) ( 31015401)
- Medication use (beta blocking agents) ( 31015401)
- Medication use (calcium channel blockers) ( 31015401)
- Medication use (diuretics) ( 31015401)
- Menarche (age at onset) ( 23667675)
- Metabolic syndrome ( 31589552)
- Neuritic plaque ( 31497858)
- Pursuit maintenance gain ( 29064472)
- Systolic blood pressure ( 27841878)
- Triglyceride levels ( 30698716)
- Triglyceride levels in current drinkers ( 30698716)
- Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) ( 30698716)
- Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) ( 30698716)
- Triglycerides ( 30275531)
- Type 2 diabetes ( 28566273 30054458 30297969 22158537 28869590)
- Urate levels ( 31578528)
- Waist-to-hip ratio adjusted for BMI ( 26426971)
- Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour) ( 28443625)
- Waist-to-hip ratio adjusted for BMI (age >50) ( 26426971)
- Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction) ( 28448500)
- Waist-to-hip ratio adjusted for BMI x sex interaction ( 26426971)
- Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test) ( 26426971)
- Waist-to-hip ratio adjusted for body mass index ( 25673412 28448500)
|
| Interacting Genes |
157 interacting genes:
ABHD14B
ACTB
ACTN1
AMOTL2
ANKRD12
ARHGAP28
ASAP3
ASCL1
ATIC
ATP5MC3
BAG6
BAZ1A
BAZ1B
C10orf90
CALR
CAND1
CANX
CCDC167
CD99
CHD4
CIAO2B
CIT
CLASP1
CMIP
CNP
COG1
COL9A2
COMT
COX11
CTNNA1
CTPS2
CUL3
CUL7
CYP27C1
DDHD2
DDX52
DPM1
ECE1
ECE2
EEF1G
EMC7
EMD
ENO2
EPS15
EXOC1
F8A1
FAM241B
FDXR
FLNA
FN1
FSTL1
GALNS
GAPDH
GATAD2B
GBA2
GEMIN2
GFPT2
GNA11
GNA13
GNAI1
GNAI2
GNAI3
GNB1
GNB4
GPR50
H2AC6
HDAC10
HIVEP2
HMGN2
HMOX2
HNRNPA0
HNRNPH1
HSPA5
IPO9
IRS4
ITPR3
KLHL12
KLHL20
KLHL5
KPNB1
LAPTM4A
LIPE
LPP
LRP3
LRRC59
MAMLD1
MCC
MESD
MMP2
MMS19
MPDZ
MTNR1B
MYO9A
NAP1L1
NAP1L4
NAP1L5
NASP
PAXIP1
PCDHB10
PDIA6
PEX14
PGRMC1
PKD1L2
PPP2R3C
PRELID1
PSMD2
PSME4
PTPN13
PTPRD
PTX3
RAB10
RAC1
RACK1
RAP1A
RBM39
RGS12
RNF2
RNF41
RPL3
RTRAF
SLC2A3
SLC30A1
SLC6A3
SLIT1
SNAPIN
SOX11
SRI
STXBP1
SUCLA2
SURF4
SVEP1
TLN1
TM9SF1
TMEM14A
TMEM230
TMEM33
TMX2
TPP2
TRIP12
TUBB
TVP23B
UBA1
UBAP2L
UBQLN1
UBR4
USP28
USP32
USP34
VAPB
VARS1
WAPL
WASHC4
YWHAB
YWHAZ
ZC3H11A
ZDHHC16
ZNF460
|
2 interacting genes:
FLNA
MTNR1A
|
| Entrez ID |
4543 |
80790 |
| HPRD ID |
02812 |
10839 |
| Ensembl ID |
ENSG00000168412
|
ENSG00000153815
|
| Uniprot IDs |
P48039
|
A0A087WU05
Q8IY22
|
| PDB IDs |
6ME2
6ME3
6ME4
6ME5
|
|
| Enriched GO Terms of Interacting Partners? |
|
|
| Tagcloud ? |
|
|
| Tagcloud (Difference) ? |
|
|
| Tagcloud (Intersection) ? |
|